Dr. Lulu Jiang's lab focuses on understanding the mechanisms behind Alzheimer's disease, particularly how RNA modifications affect the disease's progression. They study how tau protein aggregates can alter RNA methylation, leading to neuronal dysfunction. The lab employs innovative techniques to explore new therapeutic strategies that could help in treating Alzheimer's and related disorders.

Dr. Nigel Paul Pedersen's lab at the University of California, Davis, focuses on understanding and improving sleep and memory in patients with epilepsy. By exploring the connections between sleep quality and cognitive function, particularly in the context of epilepsy, the lab aims to develop innovative therapeutic strategies. The research combines behavioral assessments, innovative models, and neural recordings to investigate how enhancing sleep can mitigate seizures and cognitive impairments in epilepsy patients.

Dr. Phyllis C. Zee's lab focuses on understanding sleep disorders, especially Delayed Sleep-Wake Phase Disorder (DSWPD) and insomnia in older adults. The lab investigates the physiological and behavioral factors that influence sleep quality and cognitive function. By examining different phenotypes of sleep disorders and their underlying mechanisms, the research aims to develop personalized treatment strategies to improve sleep and overall health in affected individuals.

Dr. Yongsoo Kim's lab at Penn State University focuses on understanding how specific brain regions, particularly the ventral claustrum-dorsal endopiriform nucleus, influence social behavior and emotional processing. The lab investigates these mechanisms using advanced techniques in neuroscience and genetics, aiming to unravel the underlying biological pathways involved in neurodevelopmental and psychiatric disorders. By studying the impact of certain genes on brain connectivity and functioning, the research seeks to inform future therapeutic strategies for various neurological conditions.

Scott A Small's lab at Columbia University Health Sciences focuses on understanding the role of the SORL1 gene in Alzheimer's disease. They investigate how different variants of this gene contribute to the disease's development and progression, particularly through its interaction with the retromer trafficking complex. The lab aims to decipher the mechanisms behind these variants to inform potential therapies for patients with Alzheimer's, especially those with specific genetic mutations.

Dr. Anthony A Grace's lab at the University of Pittsburgh explores how early stress impacts brain function differently in males and females. By studying rats, the lab examines how stress during critical developmental periods can lead to long-lasting changes in brain circuitry and behavior. The research aims to understand the mechanisms behind these differences to improve early interventions for psychiatric disorders that can develop later in life.

Dr. Robert J. Vassar's lab at Northwestern University focuses on understanding the mechanisms behind Alzheimer's disease (AD), particularly how specific proteins contribute to neuron degeneration and tau pathology. The lab investigates the roles of angiotensin converting enzyme (ACE1) and the protein annexin A6 in neuronal health and disease. Through their studies, they aim to discover new therapeutic strategies for AD by exploring the fundamental biological processes that lead to memory loss and cognitive decline.

Dr. Giulio Taglialatela's research lab focuses on understanding the early molecular events that cause Alzheimer's Disease (AD), specifically how different forms of toxic tau protein impact synapses in the brain. The lab investigates why some individuals can remain cognitively healthy despite having signs of AD pathology, aiming to develop new therapies that protect synapses from tau-induced damage. Through this work, the lab seeks to uncover the mechanisms behind synaptic resilience and vulnerability in neurological diseases.

Dr. Jennifer Jean Lentz's lab at LSU Health Sciences Center focuses on understanding Usher syndrome, a rare condition that affects hearing, vision, and balance. The lab aims to uncover the mechanisms behind vestibular dysfunction and develop innovative therapies for this disorder. Through animal models and patient studies, the lab seeks to improve treatment options and provide insights for future clinical trials.

Dr. Rui Chang's lab at Yale University focuses on understanding how the brain senses signals from the body's internal organs through the vagus nerve. Using advanced molecular and genetic techniques, the lab investigates the architecture and functioning of this vital communication pathway. Their research aims to reveal how different visceral inputs are encoded and processed, paving the way for new insights into health and disease related to interoception, or the sense of the internal state of the body.

Dr. Andrew P. Yonelinas' lab at UC Davis focuses on understanding the role of the medial temporal lobes (MTL) in visual perception and working memory. Their research addresses how damage or age-related changes to the MTL can impact our ability to perceive visual information, especially in complex scenarios. By combining psychophysical methods, eye tracking, and advanced brain imaging, they aim to clarify the neural mechanisms that support our visual cognition and how various conditions like Alzheimer's and schizophrenia may affect these processes.

Dr. Joshua Trachtenberg's lab at UCLA focuses on how visual experiences during early development influence the formation of neural circuits in the brain. They specifically investigate the development of binocular vision and the mechanisms behind visual plasticity, using advanced techniques to track neural activity in awake animals. This research not only enhances our understanding of brain development but also holds implications for therapeutic strategies to address neural circuit disruptions later in life.

Dr. Brian Trainor's lab studies how exposure to social stress during adolescence affects brain circuits related to social behavior, particularly focusing on the role of androgens (male hormones). By using California mice as a unique model, his research explores how hormonal changes in puberty might alter neural circuits and influence behaviors associated with stress, such as anxiety and social vigilance. This work aims to uncover the mechanisms behind gender differences in stress-related mental illnesses.

Dr. Emily Gilmore's lab at Yale University focuses on understanding how certain brain patterns, referred to as electrographic seizures (ESz) and high-frequency periodic discharges (HF-PD), affect recovery in patients with severe traumatic brain injury (sTBI). The lab aims to establish whether these patterns indicate a worsening brain condition and how they could be treated to improve patient outcomes. Their research is crucial as it may lead to better treatment strategies for sTBI, enhancing the likelihood of recovery for affected individuals.

Dr. Michael S Gold's lab focuses on understanding the mechanisms behind pain caused by injuries to the trigeminal nerve, which is a critical nerve responsible for sensation in the face. They investigate how this type of nerve injury differs from others in terms of its response and treatment. The lab's ultimate goal is to identify more effective therapies for alleviating pain associated with trigeminal nerve injuries by exploring changes at the molecular level, particularly with certain proteins that could be targeted for treatment.

Dr. Peter T. Tsai's lab at UT Southwestern Medical Center studies how certain brain circuits involving the cerebellum influence social behaviors. They are investigating the communication between the cerebellum and the medial prefrontal cortex and how this is important for social interactions. The research aims to uncover mechanisms underlying social behavior challenges in neurodevelopmental disorders and explore potential ways to enhance these behaviors through targeted interventions.

Dr. Kyrana Tsapkini's lab focuses on developing innovative treatments for language impairments associated with atypical Alzheimer's disease, particularly in patients suffering from logopenic variant primary progressive aphasia (lvPPA). Using a method called transcranial direct current stimulation (tDCS), they aim to enhance the effectiveness of speech-language therapy and improve cognitive functions like memory. Their research explores how targeted brain stimulation can help mitigate cognitive deficits and generalize language treatment benefits for those affected by this condition.

Dr. Richard W. Tsien's lab at NYU focuses on understanding how calcium channels in neurons influence learning and memory, particularly through a process called excitation-transcription coupling. They also investigate how oxytocin, a hormone related to social behaviors, affects the brain's neural circuits and may help with conditions like autism. By integrating biology, behavioral science, and advanced techniques, the lab aims to uncover mechanisms that link neuronal activity to behavioral outcomes.

The Tsukamoto Lab at Johns Hopkins University is focused on developing new treatments for Alzheimer's disease by targeting an enzyme called neutral sphingomyelinase 2 (nSMase2). This research aims to inhibit the production of harmful molecules that contribute to Alzheimer's pathology, potentially slowing the disease's progression. By optimizing new drug candidates and testing them in animal models, the lab hopes to find effective therapies that can improve outcomes for patients suffering from Alzheimer's.

Dr. Henry L. Paulson's lab at the University of Michigan focuses on understanding the mechanisms behind age-related neurodegenerative diseases, especially how proteins involved in cellular quality control, such as ubiquitin, contribute to these disorders. The lab aims to discover new treatments by studying how these proteins become dysfunctional and lead to diseases like Alzheimer's and Huntington's. By investigating the complex biology of these proteins, the research seeks to identify potential therapeutic targets.